Extraction and characterization of fish visceral protease from Carangoides malabaricus and its potential application in detergent and pharmaceutical industries.

Fish viscera have innumerable potential applications being the rich source of digestive enzymes, especially proteases. In order to assess the bio prospecting of fish processing wastes as natural wealth to obtain value added bioactive compounds, the visceral wastes of Carangoides malabaricus were characterized. This study involves the characterization of crude visceral protease extract from C. malabaricus and its potential application as a destainer. The optimum activity and stability of the crude visceral protease was observed at pH 9.0 and 50°C. This alkaline proteolytic crude extract was then tested for its potential application as destainer and it showed better stain removing efficiency. Characterization studies revealed that metal ions like Calcium chloride, surfactants like Tween 20 and SDS, inhibitors like PMSF influenced the activity and stability of the crude Visceral Protease. The present study also inferred that, crude visceral protease enzyme from C. malabaricus along with shrimp shell hydrolysate displayed higher DPPH radical scavenging activity (58.11%), Reducing activity (1.89 mg/ml) and Chelating ability (73.6%). As a whole, this study confirmed possible application of Visceral Protease from C. malabaricus in detergent and pharmaceutical industries

Defence Applications of Polymer Nanocomposites

The potential opportunities promised by nanotechnology for enabling advances in defence technologies are staggering. Although these opportunities are likely to be realised over a few decades, many advantages are currently being explored, particularly for defence applications. This review provides an insight into the capabilities offered by nanocomposites which include smart materials, harder/lighter platforms, new fuel sources and storage as well as novel medical applications. It discusses polymer-based nanocomposite materials, nanoscale fillers and provides examples of the actual and potential uses of nanocomposite materials in defence with practical examples.Defence Science Journal, 2010, 60(5), pp.551-563, DOI:http://dx.doi.org/10.14429/dsj.60.57

Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months

Copyright \ua9 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.OBJECTIVE: This study aimed to quantify the trajectory and magnitude of change of the key clinical features and corresponding symptom domains of dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD), including global cognition, parkinsonism, recurrent visual hallucinations, cognitive fluctuations, and sleep disturbance. METHODS: One hundred sixteen patients with Lewy body dementia (DLB = 72, PDD = 44) underwent assessment at baseline and 3 and 6 months as part of a prospective multicenter randomized controlled trial. Linear mixed models were constructed for core outcome measures using the Mini-Mental State Examination (MMSE), motor section of the Unified Parkinson\u27s Disease Rating Scale (UPDRS-III), Dementia Cognitive Fluctuations Scale (DCFS), and Neuropsychiatric Inventory (NPI). RESULTS: Within the time frame of our study (6 months), we were able to identify a significant cognitive decline of 1.3 points on the MMSE (p = 0.002) and significant worsening of motor parkinsonism with an increase in UPDRS-III score of 3.2 points (p = 0.018). Fluctuation severity also increased using the DCFS with a 6-month change in score of 1.3 points (p = 0.001). Uniquely, a signal for increased severity of sleep symptoms of 1.2 points (NPI-sleep) was also detectable (p = 0.04). Significant changes in neuropsychiatric symptoms were not detected. There was no difference in rates of change of scores between DLB and PDD. DISCUSSION: Clinically significant rates of change in core clinical features can be detected and quantified in Lewy body dementia over a relatively short period (6 months) using common clinical instruments and thus may be useful as clinical endpoints for therapeutic trials of disease-modifying and symptomatic agents

Introduction of an assessment toolkit associated with increased rate of DLB diagnosis.

BACKGROUND: Dementia with Lewy bodies (DLB) and dementia in Parkinson's disease (PDD) are recognised to be under-recognised in clinical practice in the UK, with only one third to a half of expected cases diagnosed. We aimed to assess whether clinical diagnostic rates could be increased by the introduction of a structured assessment toolkit for clinicians. METHODS: We established baseline diagnostic rates for DLB and PDD in four memory clinics and three movement disorder/Parkinson's disease (PD) clinics in two separate geographical regions in the UK. An assessment toolkit specifically developed to assist with the recognition and diagnosis of DLB and PDD was then introduced to the same clinical teams and diagnostic rates for DLB and PDD were reassessed. For assessing DLB diagnosis, a total of 3820 case notes were reviewed before the introduction of the toolkit, and 2061 case notes reviewed after its introduction. For PDD diagnosis, a total of 1797 case notes were reviewed before the introduction of the toolkit and 3405 case notes after it. Mean values and proportions were analysed using Student's t test for independent samples and χ2 test, respectively. RESULTS: DLB was diagnosed in 4.6% of dementia cases prior to the introduction of the toolkit, and 6.2% of dementia cases afterwards, an absolute rise of 1.6%, equal to a 35% increase in the number of DLB cases diagnosed when using the toolkit (χ2 = 4.2, P = 0.041). The number of PD patients diagnosed with PDD was not found overall to be significantly different when using the toolkit: 9.6% of PD cases before and 8.2% of cases after its introduction (χ2 = 1.8, P = 0.18), though the ages of PD patients assessed after the toolkit's introduction were lower (73.9 years vs 80.0 years, t = 19.2, p < 0.001). CONCLUSION: Introduction of the assessment toolkit was associated with a significant increase in the rate of DLB diagnosis, suggesting that a structured means of assessing symptoms and clinical features associated with DLB can assist clinicians in recognising cases. The assessment toolkit did not alter the overall rate of PDD diagnosis, suggesting that alternate means may be required to improve the rate of diagnosis of dementia in Parkinson's disease

Clinical diagnosis of Lewy body dementia

This is the final version. Available on open access from Cambridge University Press via the DOI in this recordBackground Lewy body dementia consisting of both dementia with Lewy bodies (DLB) and Parkinson’s disease (PD) dementia (PDD) is considerably under-recognised clinically compared to its frequency in autopsy series. Aims This study investigated the clinical diagnostic pathways of patients with Lewy body dementia to assess if difficulties in diagnosis maybe contributing to these differences. Methods We reviewed the medical notes of 74 DLB and 72 non-DLB dementia cases matched for age, gender and cognitive performance, together with 38 PDD cases and 35 PD cases, matched for age and gender, from two geographically distinct UK regions. Results DLB cases took longer to reach a final diagnosis (1.2v0.6 years, p=0.003), underwent more scans (1.7v1.2, p=0.017) and had more alternative prior diagnoses (0.8v0.4, p=0.002), than non-DLB cases. Cases diagnosed in one region had significantly more core features (2.1v1.5, p=0.007) than in the other and were less likely to have dopamine transporter imaging (p<0.001). For PDD cases, more than 1.4 years prior to receiving a dementia diagnosis, 46% had documented impaired activities of daily living due to cognitive impairment, 57% had cognitive impairment in multiple domains, with 38% having both, and 39% already receiving anti-dementia drugs. 3 Conclusions Our results show the pathway to diagnosis of DLB is longer and more complex than nonDLB dementia. There were also marked differences between regions in the thresholds clinicians adopt for diagnosing DLB and also in the use of dopamine transporter imaging. Whilst for PDD, a diagnosis of dementia was delayed well beyond symptom onset and even treatment.National Institute for Health Research (NIHR

Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies

$\textbf{BACKGROUND}$: Volumetric atrophy and microstructural alterations in diffusion tensor imaging (DTI) measures of the hippocampus have been reported in people with Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, no study to date has jointly investigated concomitant microstructural and volumetric changes of the hippocampus in dementia with Lewy bodies (DLB). $\textbf{METHODS}$: A total of 84 subjects (23 MCI, 17 DLB, 14 AD, and 30 healthy controls) were recruited for a multi-modal imaging (3T MRI and DTI) study that included neuropsychological evaluation. Freesurfer was used to segment the total hippocampus and delineate its subfields. The hippocampal segmentations were co-registered to the mean diffusivity (MD) and fractional anisotropy (FA) maps obtained from the DTI images. $\textbf{RESULTS}$: Both AD and MCI groups showed significantly smaller hippocampal volumes compared to DLB and controls, predominantly in the CA1 and subiculum subfields. Compared to controls, hippocampal MD was elevated in AD, but not in MCI. DLB was characterized by both volumetric and microstructural preservation of the hippocampus. In MCI, higher hippocampal MD was associated with greater atrophy of the hippocampus and CA1 region. Hippocampal volume was a stronger predictor of memory scores compared to MD within the MCI group. $\textbf{CONCLUSIONS}$: Through a multi-modal integration, we report novel evidence that the hippocampus in DLB is characterized by both macrostructural and microstructural preservation. Contrary to recent suggestions, our findings do not support the view that DTI measurements of the hippocampus are superior to volumetric changes in characterizing group differences, particularly between MCI and controls.This study is funded by the UK National Institute of Health Research Cambridge Biomedical Research Centre and Biomedical Research Unit in Dementia. JBR is supported by the Wellcome Trust (103838). JPC is supported by the UK National Institute of Health Research Biomedical Research Centre at Cambridge. PVR is supported by the PSP Association. EM is in receipt of a Gates Cambridge scholarship and an Alzheimer's Research UK Research Grant

Neuroinflammatory and morphological changes in late-life depression: the NIMROD study

We studied neuroinflammation in individuals with late-life, depression, as a risk factor for dementia, using [11C]PK11195 positron emission tomography (PET). Five older participants with major depression and 13 controls underwent PET and multimodal 3T magnetic resonance imaging (MRI), with blood taken to measure C-reactive protein (CRP). We found significantly higher CRP levels in those with late-life depression and raised [11C]PK11195 binding compared with controls in brain regions associated with depression, including subgenual anterior cingulate cortex, and significant hippocampal subfield atrophy in cornu ammonis 1 and subiculum. Our findings suggest neuroinflammation requires further investigation in late-life depression, both as a possible aetiological factor and a potential therapeutic target.The study was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre and Biomedical Research Unit in Dementia based at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge. J.B.R. is supported by the Wellcome Trust (103838). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health

Corrosion studies on 316L fusion zone and base metal in natural sea water by weight loss method

Corrosion studies were carried out on AISI 316L stainless steel weldments.Corrosion rates were measured on base metal (BM) and fusion zone (FZ) under as -received conditions. Regions welded by Tungsten Inert Gas (TIG) process display complex solidified microstructure. The corrosion tests were conducted in Arabian Sea for the durations of 1, 2 and 3 months. Weight - loss method was adopted to find the corrosion rates. Microstructures of two materials being different, offer different resistance to a given corrosive condition. The breakdown of passivity occurs by the aggressive attack of halide ions on the oxide film, the nature of which depends on the anode potential, environment and inhomogeneity on the surface of the metal. Pitting and other surface variations like layer formation due to sea water microbes were studied and characterization was done by Scanning electron microscope (SEM) along with Energy Dispersive Spectrometer (EDS) for finding composition of the two materials after and before exposure. Experiments showed that under as recieved condition corrosion on fusion zone were severe compared to that of parent metal